A new N-methyl thymine derivative comprising a dihydroxyisobutenyl unit as ligand for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK)

Bioorg Med Chem Lett. 2011 Oct 15;21(20):6161-5. doi: 10.1016/j.bmcl.2011.07.115. Epub 2011 Aug 6.

Abstract

Molecular modeling and phosphorylation assay in vitro were employed to select a novel unsaturated 1,3-dihydroxyisobutenyl thymine derivative 6 as ligand for HSV-1 TK which may be of interest as lead for the development of an positron emission tomography (PET) imaging agent. Compound 6 was successfully prepared using modified approaches. A significant improvement over the syntheses involving pathways A and B (1% and 3% overall yield, respectively), was observed using synthetic route C (14% overall yield).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology*
  • Cell Line, Tumor
  • Herpes Simplex / diagnosis
  • Herpes Simplex / enzymology*
  • Herpesvirus 1, Human / enzymology*
  • Humans
  • Models, Molecular
  • Phosphorylation
  • Positron-Emission Tomography / methods
  • Thymidine Kinase / metabolism*
  • Thymine / analogs & derivatives*
  • Thymine / pharmacology*

Substances

  • Antiviral Agents
  • Thymidine Kinase
  • Thymine